Global Genomics Biomarkers Market 2017-2021
- SKU ID : TNV-IRTNTR11506 10436762
- |
- Publishing Date: 11-Jan-2017
- |
- Region: Global
- |
- No. of pages: 83
About Genomics Biomarkers
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
Technavio’s analysts forecast the global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global genomics biomarkers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomic biomarkers.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Genomics Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Roche Diagnostics
• Myriad Genetics
• QIAGEN
• Thermo Fisher Scientific
• Bio-Rad Laboratories
Other prominent vendors
• 23andMe
• Aepodia
• Almac Group
• AROS Applied Biotechnology
• DNAVision
• Epigenomics
• Epistem
• Eurofins Scientific
• Foundation Medicine
• Genomic Health
• Liquid Genomics
• New England Biolabs
• OriGene
• US Biomarkers
Market driver
• Genomics biomarker-based personalized medicine
• For a full, detailed list, view our report
Market challenge
• Delay in time from lab to market
• For a full, detailed list, view our report
Market trend
• Expansion of new business models
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
Technavio’s analysts forecast the global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global genomics biomarkers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomic biomarkers.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Genomics Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Roche Diagnostics
• Myriad Genetics
• QIAGEN
• Thermo Fisher Scientific
• Bio-Rad Laboratories
Other prominent vendors
• 23andMe
• Aepodia
• Almac Group
• AROS Applied Biotechnology
• DNAVision
• Epigenomics
• Epistem
• Eurofins Scientific
• Foundation Medicine
• Genomic Health
• Liquid Genomics
• New England Biolabs
• OriGene
• US Biomarkers
Market driver
• Genomics biomarker-based personalized medicine
• For a full, detailed list, view our report
Market challenge
• Delay in time from lab to market
• For a full, detailed list, view our report
Market trend
• Expansion of new business models
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
